The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patients
Author:
Affiliation:
1. Clinic of Hematology Clinical Center of Serbia Belgrade Serbia
2. School of Medicine University of Belgrade Belgrade Serbia
3. Institute for Molecular Genetics and Genetic Engineering University of Belgrade Belgrade Serbia
Funder
Ministry of Education, Science and Technological Development, Republic of Serbia
Publisher
Wiley
Subject
Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13144
Reference35 articles.
1. Understanding the molecular pathogenesis of acute promyelocytic leukemia
2. Current standard treatment of adult acute promyelocytic leukaemia
3. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
4. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia
5. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups;Sanz MA;Blood,2000
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Wilms Tumor: Updates about Pathogenesis and New Possible Clinical Treatments of the Most Frequent Pediatric Urogenital Cancer: A Narrative Review;Surgeries;2023-12-08
2. Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia;Cancer Biology & Therapy;2023-11-30
3. Wilms’ tumor gene 1 in hematological malignancies: friend or foe?;Hematology;2023-09-05
4. The influence of BCL2, BAX, and ABCB1 gene expression on prognosis of adult de novo acute myeloid leukemia with normal karyotype patients;Radiology and Oncology;2023-04-20
5. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity;Future Pharmacology;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3